SCHEMBL418352

SCHEMBL418352

C1=CC2c3ccccc3C=CN2C=C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.38
▸ CCL2 P13500 1/20 0.38
▸ HTR2A P28223 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ DRD2 P14416 1/20 0.31
▸ ADRA2B P18089 1/20 0.31
▸ ADRA2C P18825 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ CHRM3 P20309 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ ADRA1A P35348 1/20 0.31
▸ HRH1 P35367 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL514156 0.93 BRD4 (0.34) BRD4CCL2HTR2AKDM4ELMNA
SCHEMBL11348748 0.86 BRD4 (0.41) BRD4CCL2HTR2AATMKDM4E
SCHEMBL18516527 0.79 FAAH (0.31) ATM
SCHEMBL18814602 0.79 — —
SCHEMBL15615571 0.75 DRD2 (0.30) DRD2
SCHEMBL8003375 0.74 BRD4 (0.35) BRD4CCL2HTR2AATM
SCHEMBL4958554 0.73 BRD4 (0.37) BRD4CCL2HTR2AATMHTR6
SCHEMBL10390576 0.73 BRD4 (0.41) BRD4CCL2HTR2AATMKDM4E
SCHEMBL17284105 0.71 BRD4 (0.36) BRD4CCL2HTR2AATM
Hydrochloric Acid SCHEMBL11111763 0.70 BRD4 (0.35) BRD4CCL2HTR2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152446-A1 NANOCATALYST COMPOSITION, METHOD FOR MAKING NANOCATALYST COMPOSITION AND HYDROCONVERSION PROCESS USING SAME INTEVEP, S.A. (VE) 2017-06-01 — — US claimed
US-20150336951-A1 Process For The Preparation Of A DPP-IV Inhibitor HOFFMANN-LA ROCHE INC. 2015-11-26 — — US claimed
US-20150252039-A1 Process For The Preparation Of Pyrido[2,1-a] Isoquinoline Derivatives By Catalytic Asymmetric Hydrogenation Of An Enamine HOFFMANN-LA ROCHE INC. 2015-09-10 — — US claimed
US-20150126743-A1 Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine HOFFMANN-LA ROCHE INC. 2015-05-07 — — US claimed
US-20150031888-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2015-01-29 — — US claimed
US-20140350257-A1 Process for the Preparation of a DPP-IV Inhibitor F. HOFFMANN-LA ROCHE AG (CH) 2014-11-27 — — US claimed
US-20140187785-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE HOFFMANN-LA ROCHE INC. (US) 2014-07-03 — — US claimed
US-20140046066-A1 PROCESS FOR THE PREPARATION OF DPP-IV INHIBITOR HOFFMANN-LA ROCHE INC. (US) 2014-02-13 — — US claimed
US-20130338366-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-A] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE HOFFMANN LA ROCHE (US) 2013-12-19 — — US claimed
US-20130109859-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE HOFFMANN-LA ROCHE INC. (US) 2013-05-02 — — US claimed
EP-2066667-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE F. Hoffmann-Roche AG (CH) 2009-06-10 — — EP claimed
US-20090105480-A1 PROCESS FOR THE PREPARATION OF A DPP-IV INHIBITOR HOFFMANN-LA ROCHE, INC. 2009-04-23 — — US claimed
WO-2009027276-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2, 1-A] ISOQUINOLINE DERIVATIVES AND POLYMORPHIC FROMS THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2009-03-05 — — WO claimed
EP-1893595-B1 PREPARATION OF (S)-4-FLUOROMETHYL-DIHYDRO-FURAN-2-ONE HOFFMANN LA ROCHE (CH) 2008-09-03 — — EP claimed
US-20080108816-A1 PROCESS FOR THE PREPARATION OF (S)-4-FLUOROMETHYL-DIHYDRO-FURAN-2-ONE F. HOFFMANN-LA ROCHE AG (CH) 2008-05-08 — — US claimed
US-20080076925-A1 PROCESS FOR THE PREPARATION OF PYRIDO [ 2-1-A] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 — — US claimed
WO-2008031749-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-20 — — WO claimed
US-20080071087-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE HOFFMAN-LA ROCHE INC. 2008-03-20 — — US claimed
WO-2008031750-A2 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-20 — — WO claimed
US-20060270853-A1 Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one HOFFMANN-LA ROCHE INC. 2006-11-30 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076925-A1 PROCESS FOR THE PREPARATION OF PYRIDO [ 2-1-A] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE PNISR, SFPQ, PLPBP BRD4 359/4885CCL2 2672/4885HTR2A 126/4885
US-20130109859-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 BRD4 108/4885CCL2 2408/4885HTR2A 60/4885
US-20150031888-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 BRD4 108/4885CCL2 2408/4885HTR2A 60/4885
US-20090105480-A1 PROCESS FOR THE PREPARATION OF A DPP-IV INHIBITOR DPP4, DPP3, DPP7 BRD4 1498/4885CCL2 3697/4885HTR2A 313/4885
US-20140046066-A1 PROCESS FOR THE PREPARATION OF DPP-IV INHIBITOR DPP4, DPP3, DPP7 BRD4 1360/4885CCL2 3626/4885HTR2A 276/4885
US-20140350257-A1 Process for the Preparation of a DPP-IV Inhibitor DPP4, DPP3, DPP7 BRD4 1498/4885CCL2 3697/4885HTR2A 313/4885
US-20080108816-A1 PROCESS FOR THE PREPARATION OF (S)-4-FLUOROMETHYL-DIHYDRO-FURAN-2-ONE DPP4, DPP7, DPP3 BRD4 2383/4885CCL2 4001/4885HTR2A 835/4885
US-20130338366-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-A] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE PNPO, ENO1, CHRM1 BRD4 983/4885CCL2 3838/4885HTR2A 470/4885
US-20150336951-A1 Process For The Preparation Of A DPP-IV Inhibitor DPP4, DPP3, DPP7 BRD4 1498/4885CCL2 3697/4885HTR2A 313/4885
US-20060270853-A1 Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one DPP4, DPP7, DPP3 BRD4 1249/4885CCL2 4022/4885HTR2A 820/4885
US-20150252039-A1 Process For The Preparation Of Pyrido[2,1-a] Isoquinoline Derivatives By Catalytic Asymmetric Hydrogenation Of An Enamine IDO2, IDO1, H1-2 BRD4 108/4885CCL2 2408/4885HTR2A 60/4885
US-20150126743-A1 Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine PNPO, ENO1, CHRM1 BRD4 983/4885CCL2 3838/4885HTR2A 470/4885
US-20140187785-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 BRD4 108/4885CCL2 2408/4885HTR2A 60/4885
US-20080071087-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE PNPO, ENO1, CHRM1 BRD4 983/4885CCL2 3838/4885HTR2A 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback